Commissioning and Professional Development
Current Projects
+ The Future of Cancer Commissioning
We are exploring how the NHSCB will handle national specialised commissioning, and what definitions will be used to decide which diseases are commissioned for on a national level. We are also exploring the future of rarer cancer patient access to drug treatments which are currently provided for under the Cancer Drugs Fund but which will end in 2013.